| Prev Close | 52.54 |
| Open | 52.44 |
| Day Low/High | 52.26 / 53.16 |
| 52 Wk Low/High | 58.46 / 82.15 |
| Volume | 15.90M |
CVS Health Corporation (CVS)
52.63
0.09
0.17
NYSE
| Exchange | NYSE |
| Shares Outstanding | 1298.40B |
| Market Cap | 69.98B |
| Div & Yield | N.A. (N.A) |
Latest News
Jim Cramer: When the Death Star Strikes
It has become almost too onerous to own something that could be in Amazon's crosshairs.
Jim Cramer: Betting That the Next Pieces of News Will Be Very Stock Heartening
The consumer is alive, well, and might benefit from a thaw with China and easy to get jobs. So would Boeing and Caterpillar.
Tesla's Debacle and 3 More Stocks to Carefully Watch
Look at the entirety of your portfolio and make sure there are no earnings blow-ups coming from the companies that you own.
Lunch Time Reading
As I sit down to eat some lunch and gather my thoughts for the afternoon, here are some of the items I'll be reading up on: · Outgoing FDA chief Scott Gottlieb raises 'concern' over Walgreens Boosts Alliance, Inc. , and CVS Health Corp. selling CBD...
Jim Cramer: Lyft Was Cooler Than Being Cool Until It Turned Ice Cold
I have had to think long and hard about Lyft, the stock, not the ride-sharing company.
Shift to CBD From Cigarettes Isn't Enough to Sustain Walgreens Stock
In fact, the de-emphasizing of cigarettes was blamed for declining same store sales.
Walgreens Market Outlook, ePharmacy Acceleration Pummel Pharmacy Stocks
The contagion in pharmacy stocks is spreading and secular trends aren't helping to find a solution anytime soon.
Is Opportunity Knocking as Walgreens Stock Suffers a Bloodletting?
Might this be the bottom? It might.
Walgreens Stock Falls After Earnings, Guidance Disappoint
Walgreens weak guidance is sending shares plummeting on Tuesday.
Gold Stocks Are Positive on a Negative Day: Here Are My 2 Favorites
While today's action isn't attractive, we were ripe for a little profit-taking.
CVS or Walgreens: Which Is the Better Dividend Stock?
While the two companies seem very similar on the surface, CVS and Walgreens are different stocks for different types of investors.
Jim Cramer: The Ultimate Case for the Leap of Taste Not Faith
I think sometimes the best way to parse the temperament is to go over the most obviously 'wrong' moves and address why they might not be wrong at all.
Boeing and CVS: Two Sagas Worth Tracking, But Just One Worth Playing Right Now
With all the unknowns surrounding Boeing it's way too early to take a position in the aircraft maker; the same is not true with CVS.
Markets, Trade Deal, Cyber Attacks, My ZTO Play: Market Recon
National security is job one. Cutting a nice deal with China that benefits both sides must come second.
Jim Cramer: I'm Not Buying This Tech Multiple Expansion
This is hope, not fact -- don't pay more for the same old thing.
Healthy Gains Ahead for Beaten-Down CVS
The market's reaction to the pharmacy giant's acquisition of Aetna is providing a rare opportunity to buy a quality company at a value price.
Jim Cramer: Here Are 6 Stocks That Will Tell You What's Going On
Why am I not more worried about a recession? Because Fed Chair Jay Powell has our back.
Sorting the Good Stocks From the 'Crocks' in 2019's Market Rally
The market rally may be a rising tide, but investors should be wary of some of the stocks it has lifted up.
Jim Cramer: For CVS the Action Is Bad, the Stock Is Cheap
This is one where many shareholders can no longer take the pain and will sell at all costs.
CVS' Massive M&A Moves Spark Skepticism on the Stock
CVS' spending spree has developed a deep debt issue for the company.
Chart of the Day: Is CVS Stock Too Cheap to Ignore?
Is CVS open to those seeking value?
Trump Administration Is No Friend to Pharmacy Benefit Managers Like CVS
Pharmacy Benefit Managers (PBMs) are in for some problems if proposed regulation is given approval.
CVS Health Better See Its General Practitioner For a Check Up
A period of repair will be needed before CVS looks attractive on the charts.
Light Forecast From CVS Health Weakens Stock
CVS is losing value for investors.
The Week Ahead: Housing, Fed Minutes and 13 Tell-Tale Earnings Reports to Watch
A shortened week still brings key economic numbers and earnings results.
